Page last updated: 2024-10-21

4-amino-1,8-naphthalimide and Colorectal Neoplasms

4-amino-1,8-naphthalimide has been researched along with Colorectal Neoplasms in 1 studies

4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"Because only 20% of hepatic cancers are operable in patients, several types of regional therapy (RT) are emerging as alternate treatment modalities."1.37Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model. ( Alcala, MA; Bartlett, DL; Kwan, SY; Lang, M; Lee, YJ; Petoud, S; Shade, CM; Uh, H; Wang, M; Weber, SG, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcala, MA1
Kwan, SY1
Shade, CM1
Lang, M1
Uh, H1
Wang, M1
Weber, SG1
Bartlett, DL1
Petoud, S1
Lee, YJ1

Other Studies

1 other study available for 4-amino-1,8-naphthalimide and Colorectal Neoplasms

ArticleYear
Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.
    Nanomedicine : nanotechnology, biology, and medicine, 2011, Volume: 7, Issue:3

    Topics: 1-Naphthylamine; Animals; Catheterization; Cell Line, Tumor; Colorectal Neoplasms; Dendrimers; Diagn

2011